Pt-Te-Nanorod-Based Photothermal Chemokine Immunotherapy for All Stages of Cancer via Adaptive and Innate Immunity.

Kang S, Gil YG, Chae SY, Jang H, Min DH.

Open source

DOI
10.1021/acsami.4c06048
Published
2024-07-15
Container
ACS Appl Mater Interfaces
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsami.4c06048,
  title = {Pt-Te-Nanorod-Based Photothermal Chemokine Immunotherapy for All Stages of Cancer via Adaptive and Innate Immunity.},
  author = {Kang S and  Gil YG and  Chae SY and  Jang H and  Min DH.},
  year = {2024},
  journal = {ACS Appl Mater Interfaces},
  doi = {10.1021/acsami.4c06048},
  url = {https://doi.org/10.1021/acsami.4c06048}
}

RIS

TY  - JOUR
TI  - Pt-Te-Nanorod-Based Photothermal Chemokine Immunotherapy for All Stages of Cancer via Adaptive and Innate Immunity.
AU  - Kang S
AU  -  Gil YG
AU  -  Chae SY
AU  -  Jang H
AU  -  Min DH.
PY  - 2024
JO  - ACS Appl Mater Interfaces
DO  - 10.1021/acsami.4c06048
UR  - https://doi.org/10.1021/acsami.4c06048
ER  - 

APA

S, K., YG, G., SY, C., H, J., & DH., M. (2024). Pt-Te-Nanorod-Based Photothermal Chemokine Immunotherapy for All Stages of Cancer via Adaptive and Innate Immunity.. ACS Appl Mater Interfaces. https://doi.org/10.1021/acsami.4c06048

Source records